DAX6.693-1,4%  Dow12.766-1,0%  Euro1,3173-0,9% 
ESt502.481-1,7%  Nas2.905-0,8%  Öl117,3-1,2% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.717-0,7% 
Home > Aktien > Enzo Biochem Aktie > Nachrichten zu Enzo Biochem

Enzo Biochem Aktie [WKN: 865607 / ISIN: US2941001024]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Enzo Biochem Inc.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Enzo Biochem Inc.

29.03.10Enzo Biochem Says Favorable Patent Appeals Court Decision Will Allow Pursuit of Claim for Substantial Damages
17.03.10Enzo Biochem Announces Supply and Distribution Agreement with Cancer Genetics
15.03.10Enzo Biochem’s Clinical Lab Division Enters Exclusive Agreement with Novel Sequencing Provider MultiGEN Diagnostics, Inc.
12.03.10Enzo Biochem Reports Results for Second Fiscal Quarter
10.03.10Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2010 Results for March 15, 2010, at 8:30 AM E.T.
04.03.10Enzo Biochem Names Robert Boorstein, MD, PhD, Medical Director of Enzo Clinical Labs
01.03.10Enzo Biochem Announces Favorable Judgment by U.S. Patent Office in an Interference against Bayer HealthCare for a Universal Diagnostic Detection System
29.01.10Enzo Biochem is Well Positioned for New Paradigms in Biotech and Healthcare, Annual Meeting is Told
13.01.10Enzo Biochem Reports That Its Clinical Labs Division Has Available Newly Authorized Swine Flu (H1N1) Test
10.12.09Enzo Biochem Reports Sharply Improved First Quarter Results
10.12.09Enzo Biochem’s Clinical Labs Division Signs Exclusive Marketing Agreement with Ikonisys for Proprietary Molecular-Based Cervical Cancer Test
07.12.09Enzo Biochem Schedules Teleconference to Discuss First Quarter 2010 Results for December 11, 2009, at 8:30 AM E.T.
25.11.09Enzo Biochem, Inc. Announces Departure of Its Secretary and Treasurer
18.11.09Enzo Biochem’s Clinical Lab Enters Exclusive Agreement with GeneNews to Market Blood Test for Colorectal Cancer
13.11.09Enzo Biochem Executive to Discuss Oral Immune Regulation Platform at Windhover TA Partnerships 2009 Conference
11.11.09Enzo Biochem to Present at Lazard Capital Markets 6th Annual Healthcare Conference
04.11.09Enzo Biochem Executive Says Oral Immune Regulation Platform Shows "Therapeutic Promise”
02.11.09Enzo Biochem Reports on Favorable Clinical Trial of EGS21 for Treatment of Non-Alcoholic Steatohepatitis
15.10.09Enzo Biochem’s Life Sciences Subsidiary Unveils Comprehensive Menu of Epigenetics Tools at Society for Neurosciences Meeting
14.10.09Enzo Biochem Reports Record Fiscal 2009 and Fourth Quarter Revenues
13.10.09Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Year-End 2009 Results for October 15, 2009, at 8:30 AM E.T.
07.10.09Enzo Biochem’s Life Sciences Division Introduces a Rapid, No-Wash Apoptosis Assay for Cytotoxicity Screening
01.10.09Enzo Biochem Life Science Unit and BioTek Instruments Form Strategic Collaboration to Provide Innovative System for the Study of Live Cells
21.09.09Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo’s Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis
18.09.09Dr. Kevin Krenitsky, President of Enzo Clinical Labs, to Present At 27th Annual Lab Institute
17.09.09Enzo Biochem’s Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components
16.09.09Enzo Biochem to Present at UBS Global Life Sciences Conference
09.09.09Enzo Biochem to Present at Thomas Weisel Partners 2009 Healthcare Conference
08.09.09Enzo Biochem Appoints Dr. Mohan Chellani, 15-Year Industry Veteran, Vice President of Scientific Affairs at Enzo Clinical Labs
08.09.09Enzo Biochem to Present at Rodman & Renshaw Annual Global Investment Conference
15.06.09Enzo Biochem Announces Record 2009 Fiscal Third Quarter Revenues
15.06.09Enzo Biochem Schedules Teleconference to Discuss Fiscal 2009 Third Quarter Results on Tuesday, June 16, 2009, at 8:30 AM E.T.
02.06.09Data from Enzo Therapeutics’ Phase II Study of Crohn’s Disease Presented at Prestigious Gastroenterology Conference
11.05.09Enzo Biochem Life Sciences Unit Awarded Patent For Increasing Detectability of Proteins and Pathogens
03.04.09Enzo Biochem Clinical Labs Subsidiary Announces Regional Services Contract with Horizon Blue Cross Blue Shield of New Jersey
12.03.09Enzo Biochem Acquires Assay Designs, Inc. Further Expanding Life Sciences Operations
12.03.09Enzo Biochem Reports Record Second Quarter Revenue
10.03.09Enzo Biochem Schedules Teleconference to Discuss Fiscal 2009 Second Quarter Results on Friday, March 13, 2009, at 8:30 AM E.T.
06.03.09Enzo Biochem Names Kevin Krenitsky President of Enzo Clinical Labs
22.01.09Enzo Biochem Tells Annual Meeting Growth in Life Sciences is Driving Revenue Gains in Fiscal 2009

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon